Free Trial

Iovance Biotherapeutics (IOVA) SEC Filings & 10K Form

Iovance Biotherapeutics logo
$3.13 -0.16 (-4.86%)
Closing price 04:00 PM Eastern
Extended Trading
$3.13 0.00 (0.00%)
As of 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Iovance Biotherapeutics SEC Filings

DateFilerForm TypeView
07/17/2025
7:12 PM
BlackRock, Inc. (Filed by)
Iovance Biotherapeutics (Subject)
Form SCHEDULE 13G/A
07/15/2025
6:36 AM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
4:15 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
4:15 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
3:46 PM
Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:47 PM
BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:49 PM
GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:50 PM
Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:51 PM
Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
4:15 PM
Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2025
4:00 PM
Iovance Biotherapeutics (Filer)
Form ARS
04/28/2025
4:00 PM
Iovance Biotherapeutics (Filer)
Form DEF 14A
04/28/2025
4:05 PM
Iovance Biotherapeutics (Filer)
Form DEFA14A
03/18/2025
7:30 PM
Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM
Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM
BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM
GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM
Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM
Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM
Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM
BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:33 PM
Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:30 PM
GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:31 PM
Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:15 PM
Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/12/2025
4:17 PM
Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:22 AM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
4:59 PM
BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:00 PM
GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:01 PM
Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:15 PM
Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:16 PM
Iovance Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/02/2024
4:25 PM
Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/21/2024
4:15 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:50 PM
Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
11/12/2024
6:11 PM
Iovance Biotherapeutics (Subject)
Maynard Ryan D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
8:03 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
4:15 PM
Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
7:38 AM
Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
5:30 PM
BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
5:32 PM
GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
10/16/2024
5:33 PM
Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:52 PM
Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:53 PM
BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:54 PM
GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:56 PM
Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
4:16 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:10 PM
Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IOVA) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners